TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Clinical trial NCT00739882 · TERMINATED

Trial details

NCT number: NCT00739882
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Plaque Psoriasis

Start date: 2008-04-01
Primary completion: 2009-06-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.